They also investigated miRNAs that could predict the transition from mild cognitive impairment (MCI) to Alzheimer’s disease .

Two new papers by a team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also, critically, to predict the conversion ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

Cognitive health start-up Ivory unveils #TimeToAct on World Alzheimer’s Day: Our Bureau, Mumbai Thursday, September 19, 2024, 16:10 Hrs [IST] Ivory, a cognitive health start-up ...

The clearance adds a Centiloid scale tool to GE Healthcare’s Mim software to help clinicians determine the density of amyloid plaque.

In a major advance for canine cognitive research, Dr. Evan MacLean and his team at the Arizona Cognition Center, part of the ...

Developmental Delay (DD): A delay in one or more of the following areas of childhood development: cognitive development ... A universal screening tool is used as part of the RTI process. Visual ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Using advanced artificial intelligence algorithms, scientists are hoping to identify brain wave patterns associated with the ...

Nearly 7 million Americans are living with Alzheimer's disease, the fifth leading cause of death among those 65 and older. The disease will carry an estimated $360 billion ...

Cambridge Vision Technology utilises AI-based technology to detect Alzheimer’s disease early on by using ocular biomarkers ...

Background: The mechanism of cognitive impairment in hemodialysis patients is multifactorial ... Transcranial Doppler (TCD) ultrasound is a noninvasive, convenient tool that is capable of performing ...